Tweets
Completed early RA prevention trial!
One dose of Rituximab at day zero in the PRAIRI Trial, delayed onset of RA diagnosis.
After 36 months mo difference .
@karen_kc123 @RheumNow #RNL2022 https://t.co/R3639V6b07
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
4 years 4 months ago
Patient-centered, holistic approach in #multimorbidity management.
🔑 Patients with #RA and #MM need help and coaching in guiding and directing their care.
🔑 Good communication with healthcare provider is the key.
@RheumNow #RNL2022 https://t.co/iLrZAT0y9r
Elena MyasoedovaMD @MyasoedovaElena ( View Tweet )
4 years 4 months ago
Approaching comorbidities!
Elena Myasoedova @RheumNow #RNL2022 https://t.co/Y3JNsBT9bJ
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
4 years 4 months ago
Thanks for coming to RheumNow Live! We'll see you next year! #RNL2022
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
"Remember bony growth is a feature of the PsA joint and one potential way in which IL17s may target the disease." Dr. B. Kirkham discusses potential synergistic activity of IL17A and TNFi in the SpA joint. #RNL2022 @RheumNow https://t.co/L9uZqoen2w
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
"Instead of using the term moderate to severe PsO, I use systemic treatment eligible PsO," when thinking about medications for PsO patients. Dr. B. Strober. #RNL2022 @RheumNow
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
Do you use Otezla with biologics in PsA? #RNL2022 @RheumNow
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
IL-17i -
Good Long term safety profile and low malignancy risk
Best efficacy for nail psoriasis
@RheumNow #RNL2022 https://t.co/8T7wAGJChF
Robert B Chao, MD @doctorRBC ( View Tweet )
4 years 4 months ago
"The most important thing to consider is what is the risk of PsO on the overall health (of the patient.)" BSA > 10% showed increase all cause mortality rates in IHOPE study. Dr. K. Gordon discusses PsO treatment complexity and importance at #RNL2022 @RheumNow https://t.co/ouHPbLmlqD
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
Have you seen the MTX data regarding PsO? Dr. Gordon reviews the METOP data. My take homes: MTX has moderate efficacy and takes a long time! #RNL2022 @RheumNow https://t.co/B28onPUKn8
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 4 months ago
Excellent charts presented by Dr. Kenneth Gordon on the PASI response and QoL response amongst different PsO therapies
@RheumNow #RNL2022 https://t.co/e3gqcPzk79
Robert B Chao, MD @doctorRBC ( View Tweet )
4 years 4 months ago
How to treat #psoriasis #PsO Indivualize for pt. OK to try more than one drug within a class if initial fails or isn’t tolerated. Common I think to have 2ndary loss of response even with dose escalation. Skin is sneaky immunologically! #RNL2022 @RheumNow https://t.co/pFPNCVLSvk
Janet Pope @Janetbirdope ( View Tweet )
4 years 4 months ago
